Combined HIV prevention for young men at risk
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study tests an all-in-one HIV prevention package for young men at higher risk of HIV. It combines a new long-acting PrEP (injectable HIV prevention) with mobile health support and sexually transmitted infection prevention. The goal is to see if this comprehensive approach works better than standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 29 years old.
- You have had anal sex with a man in the last 6 months.
- You meet at least one of these risk factors in the last 6 months: had sex without a condom (outside a monogamous relationship), had 2 or more male partners, been diagnosed with an STI (gonorrhea, chlamydia, syphilis), or used stimulants (like cocaine or meth).
- You are not currently on PrEP and have not used it in the past 3 months.
- You are interested in learning about or starting PrEP.
- You own a smartphone (iPhone or Android) and are willing to use it for the study.
- You do not have HIV and are not on certain other research studies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a '2-1-1' on-demand PrEP strategy for cisgender men who have sex with men. It aims to see if taking PrEP only around the time of sex is safe and effective. If you are interested in starting or currently taking PrEP this way, you may be eligible.
This study compares different ways to help young men learn about and choose PrEP, a medicine that prevents HIV. It aims to see which approach works best for starting and staying on PrEP.
This trial tests a new way to take HIV prevention medicine (PrEP) only around the time you have sex, using a pill called TAF/FTC. It aims to see if this 'on-demand' method is effective, safe, and acceptable, and could offer a more flexible option than taking a pill every day.
This study tests a mobile app to help young men who have sex with men stay HIV-negative. It focuses on people who have had condomless anal sex recently and are not using PrEP.
This study tests a new approach to help young gay and bisexual men who take PrEP medication prevent HIV but sometimes miss doses or have condomless sex. It aims to see if behavioral strategies can improve adherence to PrEP and reduce risky behaviors.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
Hear when a new Sexually Transmitted Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.